ODD: 10 μLantiserum vs 5 μLAcute phase serum, WB: 100 μLantiserum vs 5 μLAcute phase serum, Immunodiffusion: 0.5 μLantiserum/cm^2 in gel vs 5 μLAcute phase serum, dilutions: Neat - 1:10.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
GBS, with 0.1 % EACA, 0.01 % benzamidIne, 1 mM EDTA, and 0.099 % NaN3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Lagerung
4 °C
Informationen zur Lagerung
Store at 4 °C
Quershi, Gurbuz, Kang, Davidson: "A novel interdigitated capacitor based biosensor for detection of cardiovascular risk marker." in: Biosensors & bioelectronics, Vol. 25, Issue 4, pp. 877-82, (2009) (PubMed).